This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Abcam
Abcam plc, commonly known as Abcam, is a leading life sciences company headquartered in Cambridge, GB. Founded in 1998, Abcam has established itself as a prominent player in the biotechnology industry, specialising in the production and distribution of high-quality antibodies and related products. With a strong focus on research and development, the company serves a global market, with significant operations across Europe, North America, and Asia. Abcam's core offerings include a vast range of antibodies, proteins, and assays, which are renowned for their specificity and reliability. The company’s commitment to innovation and quality has positioned it as a trusted partner for researchers in academia and industry alike. Notable achievements include a robust portfolio of over one million products, making Abcam a go-to resource for scientists seeking advanced tools for their research.
DitchCarbon Score
How does Abcam's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Abcam's score of 48 is higher than 69% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Abcam's reported carbon emissions
In 2022, Abcam reported total carbon emissions of approximately 102,263,000 kg CO2e, with significant contributions from Scope 3 emissions, which accounted for about 102,263,000 kg CO2e. Scope 1 emissions were approximately 1,224,000 kg CO2e, and Scope 2 emissions totalled about 3,370,000 kg CO2e. The combined Scope 1 and 2 emissions reached approximately 4,594,000 kg CO2e. In 2021, the company’s global emissions were about 87,858,000 kg CO2e, with Scope 3 emissions at approximately 82,633,000 kg CO2e. Scope 1 emissions were around 1,111,000 kg CO2e, and Scope 2 emissions totalled about 4,113,000 kg CO2e, leading to combined Scope 1 and 2 emissions of approximately 5,224,000 kg CO2e. Abcam has not disclosed specific reduction targets or initiatives as part of its climate commitments, and there are no SBTi (Science Based Targets initiative) reduction targets reported. The company is a current subsidiary of Danaher Corporation, which may influence its climate strategy and reporting. Overall, Abcam's emissions data reflects a significant reliance on Scope 3 emissions, highlighting the importance of addressing supply chain impacts in their climate strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2020 | 2021 | 2022 | |
|---|---|---|---|
| Scope 1 | 1,554,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,198,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 4,752,000 | 00,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Abcam is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
